SD Biosensor, Inc (KRX:137310)

Market Cap	1.08T
Revenue (ttm)	696.13B
Net Income (ttm)	113.22B
Shares Out	119.62M
EPS (ttm)	941.16
PE Ratio	9.59
Forward PE	n/a
Dividend	200.00 (2.21%)
Ex-Dividend Date	Dec 27, 2024

Volume	53,553
Average Volume	84,095
Open	9,030.00
Previous Close	9,030.00
Day's Range	8,970.00 - 9,090.00
52-Week Range	8,380.00 - 13,550.00
Beta	0.84
RSI	43.07
Earnings Date	Feb 20, 2026

About SD Biosensor

SD Biosensor, Inc, an in-vitro diagnostic company, provides point-of-care diagnostic solutions in South Korea and internationally. The company’s products include STANDARD Q, which provides various rapid test parameters comprising COVID-19 products and other parameters; STANDARD F, a multi-parametric and random accessible FIA system that provides diagnostic results to the laboratories; and STANDARD E, an enzyme linked immunosorbent assay for mass screening tests. Its products also include STANDARD M, a point-of-care MDx system for clinical decis...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2010
• Employees: 576
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 137310

Financial Performance

In 2024, SD Biosensor's revenue was 694.57 billion, an increase of 5.93% compared to the previous year's 655.68 billion. Losses were -98.41 billion, -78.96% less than in 2023.